St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
570 hedge funds and large institutions have $13.1B invested in St Jude Medical in 2016 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 233 increasing their positions, 193 reducing their positions, and 95 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
21% more repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 193
8% less funds holding
Funds holding: 620 → 570 (-50)
11% less call options, than puts
Call options by funds: $19.3M | Put options by funds: $21.7M
21% less capital invested
Capital invested by funds: $16.6B → $13.1B (-$3.48B)
47% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 95
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$201M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$123M |
| 3 |
D.E. Shaw & Co
New York
|
+$83.7M |
| 4 |
Goldman Sachs
New York
|
+$79M |
| 5 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
+$77.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$282M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$223M |
| 3 |
Ninety One (UK)
London,
United Kingdom
|
-$176M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$60.1M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$57.3M |
STJ Hedge Fund Activity: Q1 2016 in Review
570 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q1 2016, worth a combined $13.1B — down 21% from $16.6B a quarter earlier.
Sellers outnumbered buyers: 95 funds closed out of STJ and 50 opened new positions — a net loss of 45 holders — while 193 trimmed existing stakes and 233 added.
The largest buyer was Royal London Asset Management, adding an estimated $201M. The largest seller was Fidelity Investments, cutting an estimated $282M.
- 570 institutional investors held St Jude Medical (STJ) as of Q1 2016, down from 620 in Q4 2015.
- Funds reported $13.1B of St Jude Medical stock for Q1 2016, down 21% quarter-over-quarter.
- 50 funds opened new St Jude Medical positions in Q1 2016 and 95 closed out, a net change of -45 holders.
- The largest St Jude Medical buyer in Q1 2016 was Royal London Asset Management, an estimated $201M added.
- The largest St Jude Medical seller in Q1 2016 was Fidelity Investments, an estimated $282M sold.
Based on aggregated 13F filings for Q1 2016.